LIXFREVO
Live / Allowed — First extension granted (statement of use) (as of 30 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99213735
- Mark type
- Word mark
- Filed
- 02 Jun 2025
- Published for opposition
- 11 Nov 2025
- Attorney of record
- Michael H. Jacobs
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurological disorders and nervous system disorders
Owner
- Praxis Precision Medicines, Inc., Boston, MA, US
- Praxis Precision Medicines, Inc., Boston, MA, US
Prosecution history
- 01 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jun 2026 — SOU EXTENSION 1 GRANTED
- 30 Jun 2026 — SOU EXTENSION 1 FILED
- 30 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 06 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Nov 2025 — PUBLISHED FOR OPPOSITION
- 05 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Oct 2025 — EXAMINER'S AMENDMENT ENTERED
- 10 Oct 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 Oct 2025 — EXAMINERS AMENDMENT E-MAILED
- 10 Oct 2025 — EXAMINERS AMENDMENT -WRITTEN
- 09 Oct 2025 — ASSIGNED TO EXAMINER
- 02 Jun 2025 — APPLICATION FILING RECEIPT MAILED